Obesity
12
➤ 5.4 In individuals who have obesity and are on pharmacological therapy for
weight reduction, we suggest reassessment of the lipid profile to evaluate
the risk of CVD and pancreatitis. (2|⊕
)
Technical Remark:
▶ As there are no data on the timing of lipid measurements after weight loss, we suggest
reassessment of lipids after 5% weight loss and periodically thereafter and when the
weight is stable.
➤ 5.5 In individuals with obesity, (body mass index >40 or >35 kg/m
2
with
comorbidities) who undergo bariatric surgery, we suggest measurement of
the lipid profile after bariatric surgery to assess CV risk. (2|⊕
)
Technical Remarks:
▶ Malabsorptive bariatric surgery procedures (e.g., Roux-en-Y gastric bypass) are more
effective than restrictive procedures (e.g., banding, sleeve gastrectomy) in decreasing
LDL-C levels.
▶ Both restrictive and malabsorptive procedures decrease TG.
▶ Reassess lipid profile 1 to 3 months after bariatric surgery and periodically thereafter
and when the weight is stable.
